| (D)-SOTALOL REDUCES HEART-RATE INDEPENDENT OF BETA-BLOCKADE SU YASUDA, JT BARBEY, A WELLSTEIN, RL WOOSLEY CIRCULATION 86 (4), 721-721, 1992 | | 1992 |
| 1012 Liver-specific homing ligands of colorectal cancer M Schmidt, S Flunkert, J Mazarati, A Wellstein EJC Supplements 2 (7), 90, 2009 | | 2009 |
| 1060 The anaplastic lymphoma kinase receptor inhibits the apoptotic effect of the dependence receptor unc5 S Flunkert, A Wellstein EJC Supplements 2 (7), 104, 2009 | | 2009 |
| 209 Monoclonal antibody targeting of the anaplastic lymphoma kinase (ALK) receptor A Wellstein, JJ LaConti, SE Kim, S Flachmann, E Tassi, H Juhl, AT Riegel Ejc Supplements 7 (8), 69, 2010 | | 2010 |
| 25 Ribozyme Targeting A Wellstein, AM Schulte, C Malerczyk, AT Tuveson, A Aigner, F Czubayko, ... Antiangiogenic Agents in Cancer Therapy, 423, 1998 | | 1998 |
| 31st annual meeting and associated programs of the society for immunotherapy of cancer (Sitc 2016): Part two: National harbor, md, USA. 9-13 November 2016 C Ager, M Reilley, C Nicholas, T Bartkowiak, A Jaiswal, M Curran, ... Journal for ImmunoTherapy of Cancer 4, 107-221, 2016 | 12 | 2016 |
| 321 Impact of CDK4/6 inhibitor-induced cellular senescence on stromal responses to breast cancer GT Gallanis, A Wellstein, AT Riegel Journal of Clinical and Translational Science 6 (s1), 57-57, 2022 | | 2022 |
| 35 Novel statistical methods to unlock the clinical potential of liquid biopsy sampling AP McDeed, S Jain, M Barefoot, J Ahn, A Wellstein Journal of Clinical and Translational Science 7 (s1), 9-9, 2023 | | 2023 |
| 7 Flexible probabilistic methods to unlock the clinical potential of liquid biopsy sampling AP McDeed, S Jain, M McNamara, A Wellstein, M Tan, J Ahn Journal of Clinical and Translational Science 8 (s1), 2-2, 2024 | | 2024 |
| A cancer cell spheroid assay to assess invasion in a 3D setting EB Berens, JM Holy, AT Riegel, A Wellstein JoVE (Journal of Visualized Experiments), e53409, 2015 | 130 | 2015 |
| A distinct role for secreted fibroblast growth factor-binding proteins in development KA Gibby, K McDonnell, MO Schmidt, A Wellstein Proceedings of the National Academy of Sciences 106 (21), 8585-8590, 2009 | 40 | 2009 |
| A heparin-binding growth factor secreted from breast cancer cells homologous to a developmentally regulated cytokine. A Wellstein, WJ Fang, A Khatri, Y Lu, SS Swain, RB Dickson, J Sasse, ... Journal of Biological Chemistry 267 (4), 2582-2587, 1992 | 173 | 1992 |
| A Human and Murine Pancreatic Cancer Organoid-in-Matrix Platform to Model Interactions with T Cells A Lahusen, J Cai, R Schirmbeck, A Wellstein, A Kleger, T Seufferlein, ... Available at SSRN 4532598, 0 | | |
| A method for estimating the potency of angiotensin‐converting enzyme inhibitors in man. A Wellstein, J Essig, GG Belz British journal of clinical pharmacology 24 (3), 397-399, 1987 | 21 | 1987 |
| A novel chicken embryo model for the investigation of drugs with antimetastatic properties DM Gvozdjan, ET Bowden, A Wellstein Clinical Pharmacology & Therapeutics 75 (2), P60-P60, 2004 | 2 | 2004 |
| A pancreatic cancer organoid-in-matrix platform shows distinct sensitivities to T cell killing A Lahusen, J Cai, R Schirmbeck, A Wellstein, A Kleger, T Seufferlein, ... Scientific Reports 14 (1), 9377, 2024 | | 2024 |
| A phase II study of lapatinib and capecitabine in second line treatment of locally advanced/metastatic pancreatic cancer. AR He, JJ Hwang, J Marshall, M Pishvaian, R Slack, LM Weiner, ... Journal of Clinical Oncology 29 (15_suppl), e14542-e14542, 2011 | 2 | 2011 |
| A phase II study of lapatinib and capecitabine in second-line treatment of metastatic pancreatic cancer. Z Wu, J Marshall, JJ Hwang, MJ Pishvaian, A Wellstein, LM Weiner, ... Journal of Clinical Oncology 30 (15_suppl), e14569-e14569, 2012 | 6 | 2012 |
| A role for MST4 in organelle organization and breast cancer cell vascular invasion EB Berens, M Gilardi, M Moretti, AT Riegel, A Wellstein Cancer Research 77 (13_Supplement), 908-908, 2017 | 2 | 2017 |
| A role for TGF-β in estrogen and retinoid mediated regulation of the nuclear receptor coactivator AIB1 in MCF-7 breast cancer cells KJ Lauritsen, HJ List, R Reiter, A Wellstein, AT Riegel Oncogene 21 (47), 7147-7155, 2002 | 77 | 2002 |
Achim AignerProfessor of Clinical Pharmacology, Leipzig University, Faculty of Medicine在 medizin.uni-leipzig.de 的电子邮件经过验证
